Cooperative Agreement U18DP006917
- The Comprehensive Analysis, Surveillance, and Statistics Initiative for Diabetes in the Young (CASSIDY) is a $499,914 Cooperative Agreement awarded by the National Center for Chronic Disease Prevention and Health Promotion, part of the Centers for Disease Control and Prevention (CFDA 93.988 Cooperative Agreements for Diabetes Control Programs). The award, effective September 30, 2025 through September 29, 2029, supports research, surveillance, and statistics related to diabetes in young...
- This $699,999 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC), under the Cooperative Agreements for Diabetes Control Programs (CFDA 93.988), supports the NYU LANGONE HEALTH COORDINATING CENTER FOR CASSIDY (NYU COC) located in New York. The award, effective from September 30, 2025 to September 29, 2029, funds research, surveillance, community interventions, and health system improvements targeting priority populations experiencing diabetes-related health...
- This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Cooperative Agreements for Diabetes Control Programs (CFDA 93.988) supports the establishment of a nationwide diabetes surveillance system for youth and young adults. The $500,000 award, with a performance period from September 30, 2025 to September 29, 2029, will fund research on the incidence, prevalence, risk factors, disparities, and social determinants of health related to diabetes in this...
- The federal Cooperative Agreement award of $499,972 was provided by the Centers for Disease Control and Prevention (CDC) under the Cooperative Agreements for Diabetes Control Programs (CFDA 93.988). The award was granted to Seattle Children's Hospital, doing business as Seattle Children's Research Institute, to support research, surveillance, community interventions, and health system improvements targeting diabetes prevention, management, and health equity in the Pacific Northwest. The award...
- The Centers for Disease Control and Prevention (CDC) awarded a $499,971 Cooperative Agreement under the Cooperative Agreements for Diabetes Control Programs (CFDA 93.988) to the Ann & Robert H Lurie Children's Hospital of Chicago. The award, with a performance period from September 30, 2025 to September 29, 2029, will support the "Chicago Area Surveillance, Statistics, and Analysis Network for Diabetes, with Representative Ascertainment" project. This project aims to implement...
- This federal Cooperative Agreement award, valued at $350,000.00, is funded by the Centers for Disease Control and Prevention (CDC) under the Cooperative Agreements for Diabetes Control Programs (CFDA 93.988). The award, with a period of performance from September 30, 2025 to September 29, 2028, supports Clemson University in evaluating the Health Extension for Diabetes Program, a community-clinical linkage program. The objective of the project is to implement evidence-based strategies to...
- This federal Cooperative Agreement award of $498,623.00, awarded on September 30, 2025 by the Centers for Disease Control and Prevention (CDC) under the Cooperative Agreements for Diabetes Control Programs (CFDA 93.988), supports the University of South Carolina in optimizing and projecting lifestyle behavioral interventions to sustain long-term health behaviors and outcomes in focus populations. The project aims to implement evidence-based strategies to decrease type 2 diabetes risk, improve...
- This Cooperative Agreement award, valued at $492,348.00 and awarded by the National Center for Chronic Disease Prevention and Health Promotion, is part of the Cooperative Agreements for Diabetes Control Programs (CFDA 93.988). The award will support the University of Pittsburgh in implementing evidence-based lifestyle change interventions to improve health outcomes related to diabetes. The project aims to decrease type 2 diabetes risk, improve self-care practices, enhance diabetes care...
- This federal Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Cooperative Agreements for Diabetes Control Programs (CFDA 93.988) provides $350,000.00 in funding to the University of Illinois to develop strategies for leveraging Federally Qualified Health Centers (FQHCs) as trusted community partners to improve diabetes management. The project aims to enhance diabetes prevention, self-care practices, and health equity by implementing evidence-based...
- This federal Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC), under the Cooperative Agreements for Diabetes Control Programs (CFDA 93.988), provides $499,993.00 in funding to the University of Massachusetts Medical School (UMASS Medical) to implement research on lifestyle change interventions that address diabetes prevention and management. The award runs from September 30, 2025 to September 29, 2027. As an academic medical center and research institution,...
The Comprehensive Analysis, Surveillance, and Statistics Initiative for Diabetes in the Young (CASSIDY) is a $498,891 Cooperative Agreement awarded on Sep 30, 2025 by the National Center for Chronic Disease Prevention and Health Promotion, a division of the Centers for Disease Control and Prevention (CDC). This 4-year award (through Sep 29, 2029) supports Geisinger Clinic, a non-profit healthcare organization in Pennsylvania, in implementing evidence-based strategies to address diabetes prevention, management, and health equity for young populations. The funding will be used for research, surveillance, community interventions, and health system improvements targeting priority populations experiencing diabetes-related health disparities. This award is part of the CDC's broader Cooperative Agreements for Diabetes Control Programs (CFDA 93.988), which focuses on reducing type 2 diabetes risk, improving self-care practices, enhancing diabetes care quality, and developing childhood obesity interventions as a diabetes prevention strategy.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $498.9k | 9/8/25 |